Agents that increase cellular cyclic AMP or calcium stimulate prolactin release from the 235-1 pituitary cell line
- 1 March 1985
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 109 (3) , 335-340
- https://doi.org/10.1016/0014-2999(85)90393-0
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Difference in Calcium Requirements for Forskolin-Induced Release of Prolactin from Normal Pituitary Cells and GH4C1Cells in Culture*Endocrinology, 1984
- Adenosine 3′,5′-Monophosphate (cAMP) and Calcium-Calmodulin Interrelation in the Control of Prolactin Secretion: Evidence for Dopamine Inhibition of cAMP Accumulation and Prolactin Release after Calcium Mobilization*Endocrinology, 1983
- Contractile response of the rabbit aorta to maitotoxin, the most potent marine toxin.The Journal of Physiology, 1983
- Penfluridol Decreases Secretagogue-Induced TSH, GH, and LH Secretion in vitro:A Possible Role for Calcium-CalmodulinNeuroendocrinology, 1983
- Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 cloneMolecular and Cellular Endocrinology, 1982
- Phenothiazines inhibit prolactin secretion in vitroFEBS Letters, 1981
- Gammaflow: A Completely Automated Radioimmunoassay SystemScience, 1976
- Growth Hormone Releasing Factor of Microbial OriginNature, 1974
- PROMOTION OF PITUITARY PROLACTIN RELEASE IN RATS BY DIBUTYRYL ADENOSINE 3′,5′-MONOPHOSPHATEJournal of Endocrinology, 1972
- Stimulation of Intestinal Adenyl Cyclase by Cholera ToxinNature, 1971